Danny L. Dearen - 16 Sep 2025 Form 3 Insider Report for InspireMD, Inc. (NSPR)

Role: Director
Signature: /s/ Danny L. Dearen
Issuer symbol: NSPR
Transactions as of: 16 Sep 2025
Net transactions value: $0
Form type: 3
Filing time: 24 Sep 2025, 16:00:13 UTC
Previous filing: 18 Mar 2025
Next filing: 14 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Dearen Danny L.	Director	C/O INSPIREMD, INC., 6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI	/s/ Danny L. Dearen	23 Sep 2025	0001756438

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NSPR	Common Stock						58,017	16 Sep 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NSPR	Options to purchase common stock (right to buy)							16 Sep 2025	Common Stock	28,206	$2.41	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of common stock represent (1) 2,000 shares of common stock purchased by the Reporting Person on the open market and (2) 56,017 shares of restricted stock, which vest on September 16, 2026, subject to the Reporting Person's continued service, provided that in the event that the Reporting Person is either (i) not reelected as a director at the Company's 2026 annual meeting of stockholders, or (ii) not nominated for reelection as a director at the Company's 2026 annual meeting of stockholders, any unvested shares of restricted stock will vest in full and become exercisable on the date of the decision not to reelect or nominate him (as applicable).
F2	The options vest and become exercisable on September 16, 2026, subject to the Reporting Person's continued service, provided that in the event that the Reporting Person is either (i) not reelected as a director at the Company's 2026 annual meeting of stockholders, or (ii) not nominated for reelection as a director at the Company's 2026 annual meeting of stockholders, any unvested options will vest in full and become exercisable on the date of the decision not to reelect or nominate him (as applicable).

Content

These shares of common stock represent (1) 2,000 shares of common stock purchased by the Reporting Person on the open market and (2) 56,017 shares of restricted stock, which vest on September 16, 2026, subject to the Reporting Person's continued service, provided that in the event that the Reporting Person is either (i) not reelected as a director at the Company's 2026 annual meeting of stockholders, or (ii) not nominated for reelection as a director at the Company's 2026 annual meeting of stockholders, any unvested shares of restricted stock will vest in full and become exercisable on the date of the decision not to reelect or nominate him (as applicable).

The options vest and become exercisable on September 16, 2026, subject to the Reporting Person's continued service, provided that in the event that the Reporting Person is either (i) not reelected as a director at the Company's 2026 annual meeting of stockholders, or (ii) not nominated for reelection as a director at the Company's 2026 annual meeting of stockholders, any unvested options will vest in full and become exercisable on the date of the decision not to reelect or nominate him (as applicable).